• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双相情感障碍和阿尔茨海默病共病的病理生理学:药理学和干细胞方法。

Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches.

机构信息

Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Av. Prof. Lineu Prestes 748, São Paulo, SP 05508-000, Brazil.

Departamento de Neurologia e Neurociências, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Pedro de Toledo 669, São Paulo, SP 04039-032, Brazil.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt A):34-53. doi: 10.1016/j.pnpbp.2017.04.033. Epub 2017 May 3.

DOI:10.1016/j.pnpbp.2017.04.033
PMID:28476640
Abstract

Neuropsychiatric disorders involve various pathological mechanisms, resulting in neurodegeneration and brain atrophy. Neurodevelopmental processes have shown to be critical for the progression of those disorders, which are based on genetic and epigenetic mechanisms as well as on extrinsic factors. We review here common mechanisms underlying the comorbidity of Bipolar Disorders and Alzheimer's Disease, such as aberrant neurogenesis and neurotoxicity, reporting current therapeutic approaches. The understanding of these mechanisms precedes stem cell-based strategies as a new therapeutic possibility for treatment and prevention of Bipolar and Alzheimer's Disease progression. Taking into account the difficulty of studying the molecular basis of disease progression directly in patients, we also discuss the importance of stem cells for effective drug screening, modeling and treating psychiatric diseases, once in vitro differentiation of patient-induced pluripotent stem cells provides relevant information about embryonic origins, intracellular pathways and molecular mechanisms.

摘要

神经精神疾病涉及多种病理机制,导致神经退行性变和脑萎缩。神经发育过程已被证明对这些疾病的进展至关重要,这些疾病基于遗传和表观遗传机制以及外在因素。我们在这里回顾了双相情感障碍和阿尔茨海默病共病的常见机制,例如异常的神经发生和神经毒性,并报告了当前的治疗方法。这些机制的理解先于基于干细胞的策略,作为治疗和预防双相情感障碍和阿尔茨海默病进展的新治疗可能性。考虑到直接在患者中研究疾病进展的分子基础的困难,我们还讨论了干细胞在有效药物筛选、疾病建模和治疗中的重要性,因为患者诱导的多能干细胞的体外分化提供了关于胚胎起源、细胞内途径和分子机制的相关信息。

相似文献

1
Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches.双相情感障碍和阿尔茨海默病共病的病理生理学:药理学和干细胞方法。
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt A):34-53. doi: 10.1016/j.pnpbp.2017.04.033. Epub 2017 May 3.
2
Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets.多功能小胶质细胞与阿尔茨海默病:多样性、工具与治疗靶点
J Mol Neurosci. 2016 Nov;60(3):390-404. doi: 10.1007/s12031-016-0825-5. Epub 2016 Sep 22.
3
Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease.诱导多能干细胞的最新研究方法与挑战:阿尔茨海默病的建模与细胞治疗
Rev Neurosci. 2016 Jul 1;27(5):457-64. doi: 10.1515/revneuro-2015-0054.
4
Alzheimer's disease, dementia, and stem cell therapy.阿尔茨海默病、痴呆症与干细胞疗法。
Stem Cell Res Ther. 2017 May 12;8(1):111. doi: 10.1186/s13287-017-0567-5.
5
Neurodegeneration and Neuro-Regeneration-Alzheimer's Disease and Stem Cell Therapy.神经退行性变与神经再生——阿尔茨海默病与干细胞治疗。
Int J Mol Sci. 2019 Aug 31;20(17):4272. doi: 10.3390/ijms20174272.
6
[Modeling neurological and psychiatric disorders in vitro using induced pluripotent stem cells: highlighting findings in Alzheimer's disease and schizophrenia].[利用诱导多能干细胞在体外模拟神经和精神疾病:聚焦阿尔茨海默病和精神分裂症的研究发现]
Neuropsychopharmacol Hung. 2016 Dec;18(4):188-198.
7
Alzheimer's disease modeling: ups, downs, and perspectives for human induced pluripotent stem cells.阿尔茨海默病建模:人类诱导多能干细胞的成败与展望。
J Alzheimers Dis. 2013;34(3):563-88. doi: 10.3233/JAD-121984.
8
Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia.诱导多能干细胞在理解双相情感障碍和精神分裂症神经生物学基础中的应用。
Psychiatry Clin Neurosci. 2017 Sep;71(9):579-599. doi: 10.1111/pcn.12528. Epub 2017 May 2.
9
Alzheimer's Disease: Mechanism and Approach to Cell Therapy.阿尔茨海默病:细胞治疗的机制与方法
Int J Mol Sci. 2015 Nov 4;16(11):26417-51. doi: 10.3390/ijms161125961.
10
Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder.干细胞衍生神经元在精神分裂症和双相情感障碍靶向治疗中的发展。
Pharmacogenomics. 2017 Apr;18(5):471-479. doi: 10.2217/pgs-2016-0187. Epub 2017 Mar 27.

引用本文的文献

1
Prospective study of bipolar disorder and neurodegenerative diseases.双相情感障碍与神经退行性疾病的前瞻性研究。
NPJ Parkinsons Dis. 2024 Oct 3;10(1):184. doi: 10.1038/s41531-024-00794-z.
2
Impaired neural stress resistance and loss of REST in bipolar disorder.双相障碍患者的神经应激抵抗受损和 REST 丧失。
Mol Psychiatry. 2024 Jan;29(1):153-164. doi: 10.1038/s41380-023-02313-7. Epub 2023 Nov 8.
3
Bipolar spectrum disorders in neurologic disorders.神经疾病中的双相谱系障碍。
Front Psychiatry. 2022 Dec 21;13:1046471. doi: 10.3389/fpsyt.2022.1046471. eCollection 2022.
4
The Neuroprotective Potentiality of Flavonoids on Alzheimer's Disease.黄酮类化合物对阿尔茨海默病的神经保护潜力。
Int J Mol Sci. 2022 Nov 27;23(23):14835. doi: 10.3390/ijms232314835.
5
Characteristics of Bipolar Patients with Cognitive Impairment of Suspected Neurodegenerative Origin: A Multicenter Cohort.疑似神经退行性病因的双相情感障碍认知障碍患者的特征:一项多中心队列研究
J Pers Med. 2021 Nov 11;11(11):1183. doi: 10.3390/jpm11111183.
6
Current status and future prospects of stem cell therapy in Alzheimer's disease.干细胞疗法在阿尔茨海默病中的现状与未来前景
Neural Regen Res. 2020 Feb;15(2):242-250. doi: 10.4103/1673-5374.265544.
7
Induced pluripotent stem cells for neural drug discovery.诱导多能干细胞在神经药物研发中的应用。
Drug Discov Today. 2019 Apr;24(4):992-999. doi: 10.1016/j.drudis.2019.01.007. Epub 2019 Jan 18.
8
Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA.使用 MetaCCA 对全基因组数据进行多变量分析,以鉴定五种主要精神障碍的潜在多效基因。
J Affect Disord. 2019 Jan 1;242:234-243. doi: 10.1016/j.jad.2018.07.046. Epub 2018 Jul 17.
9
Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences.黄酮类化合物作为阿尔茨海默病和帕金森病的治疗剂:临床前证据的系统评价。
Oxid Med Cell Longev. 2018 May 10;2018:7043213. doi: 10.1155/2018/7043213. eCollection 2018.
10
Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.双相情感障碍 II 型合并酒精依赖的附加美金刚治疗:一项为期 12 周的随访研究。
Alcohol Clin Exp Res. 2018 Jun;42(6):1044-1050. doi: 10.1111/acer.13640. Epub 2018 May 17.